Current Trials for Ovarian Cancer

BMS 004 trial 

A Phase I Multiple Ascending Dose Study of BMS-663513, an Agonistic Anti-CD137 Monoclonal Antibody, Administered in Combination with Chemotherapy to Subjects with Advanced Solid Malignancies.

Principal Investigator: Amir Jazaeri, MD

For a summary of this trial click here.

Contact:  Melinh Jones, Phone: (434)243-9553, E-mail: mj9v@virginia.edu.